Yahoo
NYSE - Nasdaq Real Time Price USD

CVS Health Corporation (CVS)

82.09 -1.20 (-1.44%)
At close: May 1 at 4:00:02 PM EDT
82.18 +0.09 (+0.11%)
After hours: May 1 at 7:59:18 PM EDT
Trade CVS on Coinbase
Chart Range Bar
Loading chart for CVS

News headlines CVS Health is experiencing mixed signals as it prepares for its upcoming earnings report. Analysts project a 1.8% declinein quarterly EPS while recent regulatory updates and strategic moves could enhance its market position.

CVS Health is experiencing mixed signals as it prepares for its upcoming earnings report. Analysts project a 1.8% declinein quarterly EPS while recent regulatory updates and strategic moves could enhance its market position.

Updated 36m ago · Powered by Yahoo Scout
  • Previous Close 83.29
  • Open 83.45
  • Bid --
  • Ask --
  • Day's Range 82.07 - 83.74
  • 52 Week Range 58.35 - 85.15
  • Volume 3,823,701
  • Avg. Volume 7,868,132
  • Market Cap (intraday) 105.207B
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 59.06
  • EPS (TTM) 1.39
  • Earnings Date May 6, 2026
  • Forward Dividend & Yield 2.66 (3.24%)
  • Ex-Dividend Date Apr 23, 2026
  • 1y Target Est 96.58

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

www.cvshealth.com

219,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview: CVS

Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CVS
5.21%
S&P 500 (^GSPC)
5.62%

1-Year Return

CVS
22.52%
S&P 500 (^GSPC)
29.01%

3-Year Return

CVS
24.82%
S&P 500 (^GSPC)
73.47%

5-Year Return

CVS
26.81%
S&P 500 (^GSPC)
72.92%

Earnings Trends: CVS

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 105.69B
Earnings 1.39B

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

0
20B
40B
60B
80B
100B

Analyst Insights: CVS

View More

Analyst Price Targets

79.00
96.58 Average
82.09 Current
140.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/15/2026
Analyst Baird
Rating Action Maintains
Rating Outperform
Price Action Raises
Price Target 92 -> 94

Statistics: CVS

View More

Valuation Measures

Annual
As of 5/1/2026
  • Market Cap

    105.21B

  • Enterprise Value

    174.56B

  • Trailing P/E

    59.06

  • Forward P/E

    11.47

  • PEG Ratio (5yr expected)

    0.24

  • Price/Sales (ttm)

    0.26

  • Price/Book (mrq)

    1.40

  • Enterprise Value/Revenue

    0.43

  • Enterprise Value/EBITDA

    17.70

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.44%

  • Return on Assets (ttm)

    2.47%

  • Return on Equity (ttm)

    2.29%

  • Revenue (ttm)

    399.83B

  • Net Income Avi to Common (ttm)

    1.77B

  • Diluted EPS (ttm)

    1.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.6B

  • Total Debt/Equity (mrq)

    106.06%

  • Levered Free Cash Flow (ttm)

    5.93B

Compare To: CVS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: CVS

Fair Value

82.09 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: CVS

View More
  • US Large Cap Pick List - April 2026

    This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.

  • Managed-Care Shares Rise on Improvement in Final Medicare Advantage Rate Notice

    CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

    Rating
    Price Target
  • CVS Remains in Turnaround Mode, Shooting for Ambitious Targets Through 2028

    CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

    Rating
    Price Target
  • The Argus High-Yield Model Portfolio

    Value stocks -- a market segment that includes high-yield stocks -- outperformed growth stocks in 2022. In 2025, value stocks and growth stocks had similar returns, with growth advancing 13.8% and value returning 13.6%. That's a recent rarity, as for the past decade-plus, the performance record has favored growth. But in 2022, the rollout of COVID-19 vaccines gave a lift to some of the cyclical companies (energy and regional banks), and value stocks outpaced growth stocks that year. While growth stocks led for a few years after that, value stocks are back in the picture as investors rotate out of higher-priced AI growth stocks in search of more reasonable valuations. Value stocks tend to be more resilient in times of market uncertainty and higher volatility as they are less likely to overreact to economic news. In any event, the value sector is the place to achieve income.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: